以下文章来源于AI医疗观察 ，作者关注AI医疗的 AI医疗观察 . 响应《关于深入实施"人工智能+"行动的意见》，推动AI在医疗领域的应用，本账号发布权威资讯 当市场讨论AI医疗 的应用 时，Hims & Hers Health给出了更偏经营侧的答案。这家公司并未试图直接介入医学判断本身，而是从入口、选品与长 期关系出发，重构医疗服务的交付方式。 正因如此，如果仅将Hims理解为一家远程医疗公司，往往会低估其的战略价值。本文将从创业和公司发展的角度，一文讲清Hims的路径与模 式。 Hims是一家什么样的公司？ Hims & Hers Health 成立于2017年，总部位于美国旧金山，是一家以 DTC 数字医疗为核心的上市公司。公司最初从男性敏感健康问题切入，围 绕勃起功能障碍、脱发等需求，通过线上问诊与药品直配的方式，为用户提供更低摩擦的就医体验。 2018年，Hims 推出女性品牌 Hers，将服务范围扩展至女性脱发、心理健康、皮肤护理与体重管理等领域，逐步形成以性健康、心理健康、体重 管理与皮肤护理为核心的多品类结构。 从公司自身及监管口径来看，Hims 仍被明确界定为远程医疗平台，即 telehea ...

Creating a scalable, AInative Virtual ICU platform that drives new recurring revenue and enterprise value. SAN JOSE, CALIFORNIA / ACCESS Newswire / January 29, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in enterprise telehealth and AI-powered virtual care, today announced a strategic partnership with DocBox, the first Augmented Intelligence platform for critical care, to create a next-generation Virtual ICU operating system for hospitals worldwide. ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. 2026 is an “execution year” for Teladoc Health, CEO Chuck Divita told Healthcare Dive. The telehealth company has spent the past year focusing on a strategy shift, prioritizing international expansion, improving operating efficiency, better leveraging its mental health assets and enhancing its integrated care business. The goal is to deliver sustainable lon ...

Medicare is making a big change that will kick in at the end of the month. Through Jan. 30, Medicare will cover telehealth services, delivered to you wherever you are, including in your home. But as of the next day, coverage will end -- unless you live in a rural area and go to a medical facility for the appointment. There are a few other exceptions, but overall, Medicare is no longer broadly covering telehealth services as it did in the past. Considering this shift, will Teladoc Health (NYSE: TDOC) stoc ...

Investors with a lot of money to spend have taken a bearish stance on Hims & Hers Health (NYSE:HIMS).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.So how do we know what these investors just did? Today, Benzinga's options scanner ...

When Stephen Smith started NOCD 11 years ago, he wanted to build an app for people like himself—one of the 8.2 million Americans with obsessive-compulsive disorder (OCD)—to track their symptoms and time their therapy exercises. Most Read from Fast Company Since 2018, NOCD (pronounced “No-CD”) has provided virtual appointments with therapists specializing in OCD-focused exposure and response prevention (ERP) therapy. With more than 140 million people able to access NOCD through their insurance, the compa ...

Group 1: Collaboration and Strategy - Amgen Inc. is collaborating with Ro, a telehealth firm, to investigate barriers patients face in accessing obesity treatments, particularly GLP-1 drugs [2][3] - The collaboration aims to leverage data from Ro's platform to assess insurance coverage, prior authorization requirements, and improve patient access to GLP-1 therapies [3] - Amgen expects the observational research from this collaboration to aid in therapy development and innovate care delivery [3] Group 2: Acquisition and Oncology Focus - Amgen acquired Dark Blue Therapeutics for up to $840 million, a UK-based biotech company focused on small molecule protein degraders for acute myeloid leukemia [4] - The acquisition supports Amgen's strategy to enhance early oncology discovery and commitment to novel therapeutic mechanisms [4] Group 3: Company Overview - Amgen Inc. is a biotechnology company that develops, manufactures, and markets human therapeutics, founded in 1980 and headquartered in Thousand Oaks, CA [5]

Scottsdale, AZ, Jan. 15, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ: CISO), a leading provider of AI-powered cybersecurity software and compliance services, today announced a strategic partnership with TeleDental.com and DentalChat.com to offer Cyber Assurance Group’s CyberSimple® powered by CHECKLIGHT®, delivering cybersecurity and financial protection purpose-built for dental practices. Through this collaboration, CyberSimple® powered by CHECKLIGHT® will be made available via TeleDental.com and De ...

Today, I am putting Talkspace, Inc. ( TALK ) in the spotlight for the first time since my last article on this small cap concern in April of last year. This telehealth concern experienced 25% year-over-year growth in its most recent reported quarter. ManagementThe Busted IPO Forum is an investing group led by Bret Jensen, Chief Investment Strategist of Simplified Asset Management. Along with his team of analysts, Bret focuses on stocks that have been public for 18 months to 6 years, and that are significant ...

Today, I am putting Talkspace, Inc. ( TALK ) in the spotlight for the first time since my last article on this small cap concern in April of last year. This telehealth concern experienced 25% year-over-year growth in its most recent reported quarter. ManagementThe Busted IPO Forum is an investing group led by Bret Jensen, Chief Investment Strategist of Simplified Asset Management. Along with his team of analysts, Bret focuses on stocks that have been public for 18 months to 6 years, and that are significant ...